Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Karolinska Development in connection with the company's listing on NASDAQ OMX
Mandate

Vinge advises Karolinska Development in connection with the company's listing on NASDAQ OMX

March 31, 2011

Vinge advises Karolinska Development AB (publ) in connection with the company’s new issue of shares of series B and listing of shares of series B on NASDAQ OMX Stockholm. First day of trading is expected to be 15 April 2011.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg and Christoffer Benninge. In addition, Maria Schultzberg, Johanna Bergström and Maria Doeser (tax) as well as Claes Henriksson (IP), among other, have participated.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026